Cargando…
Mitochondria-Targeted Honokiol Confers a Striking Inhibitory Effect on Lung Cancer via Inhibiting Complex I Activity
We synthesized a mitochondria-targeted honokiol (Mito-HNK) that facilitates its mitochondrial accumulation; this dramatically increases its potency and efficacy against highly metastatic lung cancer lines in vitro, and in orthotopic lung tumor xenografts and brain metastases in vivo. Mito-HNK is >...
Autores principales: | Pan, Jing, Lee, Yongik, Cheng, Gang, Zielonka, Jacek, Zhang, Qi, Bajzikova, Martina, Xiong, Donghai, Tsaih, Shirng-Wern, Hardy, Micael, Flister, Michael, Olsen, Christopher M., Wang, Yian, Vang, Ole, Neuzil, Jiri, Myers, Charles R., Kalyanaraman, Balaraman, You, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137433/ https://www.ncbi.nlm.nih.gov/pubmed/30428319 http://dx.doi.org/10.1016/j.isci.2018.04.013 |
Ejemplares similares
-
Chemoprevention of Lung Cancer with a Combination of Mitochondria-Targeted Compounds
por: Zhang, Qi, et al.
Publicado: (2022) -
Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
por: Cheng, Gang, et al.
Publicado: (2019) -
Prevention of Tumor Growth and Dissemination by In Situ Vaccination with Mitochondria‐Targeted Atovaquone
por: Huang, Mofei, et al.
Publicado: (2022) -
Antiproliferative effects of mitochondria-targeted N-acetylcysteine and analogs in cancer cells
por: Cheng, Gang, et al.
Publicado: (2023) -
NNAT is a novel mediator of oxidative stress that suppresses ER + breast cancer
por: Plasterer, Cody, et al.
Publicado: (2023)